Debates and Controversies in Hematology

Debates and Controversies in Hematology is organized by Imedex and would be held during sep 29 - Oct 1, 2016 at InterContinental Prague, Prague, Praha, Czech Republic. This conference has been approved for AMA PRA Category 1 Credits.

The target audience for this medical event basically for European hematologists, medical oncologists, and other healthcare professionals (physicians, physicians-in-training, oncology nurses, pharmacists, physician assistants, etc.) who are involved and/or interested in the treatment of patients with hematologic malignancies and benign hematologic disorders.

Conference Objectives :
• Interpret published and ongoing clinical trial data utilizing novel therapeutic and management strategies and assess how these strategies have the potential to enhance outcomes in patients with hematologic malignancies and benign hematologic disorders
• Assess the role of standard of care regimens in the era of targeted therapy
• Evaluate how cytogenetic abnormalities can be utilized for effective diagnosis, prognosis, and therapy for hematologic malignancies and benign hematologic disorders
• Recognize disease- and therapy-associated adverse events and design effective strategies to manage them
• Formulate evidence-based strategies for the management of hematologic malignancies and benign hematologic disorders that take into consideration patient risk factors and prior therapies.